EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Irregular Antibody Screening Using a Microdroplet Platform

Ding-Ping Chen, Pei-Yu Wu, Yen-Heng Lin iD

Biosensors · 2023

DOI: 10.3390/bios13090869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, 2023. Verfasst von Ding-Ping Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan City 33305, Taiwan. Hauptthemen laut MEDLINE: Antibodies, Erythrocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council of Taiwan, Chang Gung Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The screening procedure for antibodies is considered the most tedious among the three pretransfusion operations, i.e., ABO and Rhesus (Rh) typing, irregular antibody screening/identification, and crossmatching tests. The commonly used screening method for irregular antibodies in clinics at present is a manual polybrene test (MP). The MP test involves numerous reagent replacement and centrifuge procedures, and the sample volume is expected to be relatively less. Herein, screening red blood cells (RBCs) and serum irregular antibodies are encapsulated in microdroplets with a diameter of ~300 μm for a hemagglutination reaction. Owing to the advantage of spatial limitation in microdroplets, screening RBCs and irregular antibodies can be directly agglutinated, thereby eliminating the need for centrifugation and the addition of reagents to promote agglutination, as required by the MP method. Furthermore, the results for a large number of repeated tests can be concurrently obtained, further simplifying the steps of irregular antibody screening and increasing accuracy. Eight irregular antibodies are screened using the proposed platform, and the results are consistent with the MP method. Moreover, the volume of blood samples and antibodies can be reduced to 10 μL and 5 μL, respectively, which is ten times less than that using the MP method.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntibodiesErythrocytesHexadimethrine BromideImmunologic Tests

Stichwörter der Autor:innen

dropletirregular antibodiesmanual polybrene testmicrofluidics

Substanzen

AntibodiesHexadimethrine Bromide

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan City 33305, Taiwan.
  • Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan City 33302, Taiwan.
  • Department of Electronic Engineering, Chang Gung University, Taoyuan City 33302, Taiwan.
  • Department of Biomedical Engineering, Chang Gung University, Taoyuan City 33302, Taiwan.

ORCID-Profile: Yen-Heng Lin

Förderung

  • National Science and Technology Council of Taiwan
  • Chang Gung Memorial Hospital

Zitieren

APA

Chen, D. P., Wu, P. Y., & Lin, Y. H. (2023). Irregular Antibody Screening Using a Microdroplet Platform. Biosensors. https://doi.org/10.3390/bios13090869

Vancouver

Chen DP, Wu PY, Lin YH. Irregular Antibody Screening Using a Microdroplet Platform. Biosensors. 2023. doi:10.3390/bios13090869

BibTeX
@article{Chen2023,
  author = {Chen, Ding-Ping and Wu, Pei-Yu and Lin, Yen-Heng},
  title = {Irregular Antibody Screening Using a Microdroplet Platform},
  journal = {Biosensors},
  year = {2023},
  doi = {10.3390/bios13090869}
}
Kostenlos starten →